Children and young adults formerly covered by Medicaid are losing access to medications needed to control conditions like depression, schizophrenia, ADHD, asthma and epilepsy, a new study says. Young people need to take these meds regularly to get the best results, as interruptions can cause flare-ups of their chronic health problems, researchers said. Interruptions in these meds are occurring more often in states that have experienced the biggest drops in Medicaid enrollment during the “unwinding” process that started after the end of the COVID pandemic, researchers reported recently in the journal Pediatrics. The unwinding brought an end to Medicaid eligibility rules put in place during the pandemic. For example, children and teens who use asthma inhalers were more likely to decrease use of their meds if they lived in a state with the largest drops in Medicaid enrollment, results show. “Our findings suggest that the rapid disenrollment of young people from Medicaid during the unwinding process resulted in the disruption of chronic disease therapy,” lead researcher Dr. Kao-Ping Chua, a pediatrician and health care researcher at the University of Michigan Medical School and School of Public Health, said in a news release. “As policymakers debate whether to enact drastic cuts to Medicaid funding, they should consider the possibility that doing so could similarly disrupt chronic disease therapy for children and young adults, placing them at… read on > read on >







